Abstract:Yinci Zhu, 1, 2 Zhong Zheng, 1, 2 Bihong Fan, 1, 2 Yun Sun, 1, 2 Junyu Zhai, 1, 2 Yanzhi Du 1, 2 1 Department of Reproductive Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, 200135, People's Republic of China; 2 Shanghai Key Laboratory for Assisted Reproduction and Reproductive Genetics, Shanghai, 200135, People's Republic of China Correspondence: Junyu Zhai; Yanzhi Du, Department of Reproductive Medicine, Ren Ji Hospital, Shanghai Jiao Tong University, School of Medicine, Shanghai, 200135, People's Republic of China, Tel +86-21-20284525; +86-21-20284518, Email ; Purpose: Together with ultrasound measurement of follicle size, serum estradiol (E 2 ) provides guidance for controlled ovarian hyperstimulation (COH). However, during the COH process, some patients experience decreased serum E 2 level, especially before human chorionic gonadotropin (hCG) trigger. In order to elucidate the effect of E 2 reduction as well as the role of oral contraceptive pretreatment, a retrospective study was performed in our center from 2013 to 2019. Patients and Methods: In total, 333 patients who experienced an E 2 decrease prior to hCG administration were recruited as E 2 decline group, while 333 patients with continuously E 2 increase during COH were considered as control group. Based on pretreatment strategy, the two groups were further categorized into oral contraceptive (OC) and non-OC sub-groups, and IVF and clinical outcomes were compared between paired groups. Results: Number of dominant follicles on hCG day and normally fertilized zygotes were significantly decreased in E 2 decline group, and the significantly reduced live birth rate in E 2 decline group indicated the close relationship between E 2 decline and clinical outcomes. To analyse further, we found that in patients without OC pretreatment, the pregnancy rate and live birth rate of E 2 decline group (n = 141) were significantly lower than control group (n = 136) (56.3% versus 68.0%, 50.8% versus 63.5%, respectively). However, for patients with OC pretreatment, no difference was detected between two groups, suggesting a potential effect of OC pretreatment on clinical outcomes. Conclusion: E 2 decline prior to hCG-triggering day adversely affects IVF and clinical outcomes in patients without OC pretreatment, especially fertilization rate and live birth rate. Keywords: estradiol decline, controlled ovarian hyperstimulation, oral contraceptive, in vitro fertilization, fertilization rate, live birth rate Serum estradiol (E 2 ) measurement is recognized as an indispensable parameter for follicle monitoring during controlled ovarian hyperstimulation (COH) in in vitro fertilization (IVF) cycles. 1,2 The E 2 value of different stages can be indicative for assessment and prognosis of treatment protocols when combined with other index. 3,4 Moreover, high level of serum E 2 associated with multiple follicle development in high responders may predict high risk for ovarian hyperstimulation syndrome (OHSS). 5,6 Prior to the prevalence of GnRH agonist protocols, decreased serum E 2 level before the day of human chorionic gonadotropin (hCG) administration was related to suboptimal IVF indexes even clinical outcomes. 7 Subsequently, several studies focused on the effects of serum E 2 decline in GnRH agonist protocols. A.K. Styer et al reported that decreased E 2 level before the day of hCG administration had no impact on pregnancy loss rate or live birth rate of the patients with GnRH-agonist protocol. 8 On the other side, S. Fisher et al concluded that in either standard long or flare protocol, spontaneously falling E 2 was linked to lower fertilization rate and clinical pregnancy rate compared to controls, whereas no such differences existed in patients with decreased E 2 due to deliberate protocol modification. 9 Thus, monitoring of E 2 level is closely related to drug adjustment during COH. In flare and antagonist protocols, oral contraceptive (OC) is frequently used as a pretreatment strategy before COH. Therefore, we focused on the role of E 2 drop before hCG-triggering and its relationship to OC pretreatment. Previous summary and conclusion were based mainly on two protocols and limited sample size, making the conclusion ambiguous. In order to clarify the above issues, we selected patients from a broader scale with different treatment protocols, -Abstract Truncated-

Serum progesterone before and after human chorionic gonadotropin injection depends on the estradiol response to ovarian hyperstimulation during in vitro fertilization-embryo transfer cycles

The effect of progesterone level prior to oocyte retrieval on the numbers of oocytes retrieved and embryo quality in IVF treatment cycles: an analysis of 2,978 cycles

Serum LH Levels on hCG Trigger Day Affect IVF Outcomes Intensified by Poor Ovarian Reserve and Advanced Age

The effect of elevated progesterone levels before oocyte retrieval in women undergoing ovarian stimulation for IVF treatment on the genomic profile of peri-implantation endometrium.

Comparison of Progesterone Measurement on Day Of, and Day After, HCG Administration in IVF–embryo Transfer Cycles

Recurrent Ivf Failure Is Associated With Elevated Progesterone On The Day Of Hcg Administration

Premature Progesterone Rise Positively Correlates with Clinical Pregnancy Rate in In Vitro Fertilization (IVF) and Intracytoplasmic Sperm Injection (ICSI) Patients with good Ovarian Response

A Clinical Study on the Level of Serum Low Progesterone about Luteal Phase Support for Partial Vaginal Delivery in Assisted Reproductive Technology

Serum Progesterone Concentration on Day of HCG Administration and IVF Outcome

Evolution of serum progesterone levels in the very early luteal phase of stimulated IVF/ICSI cycles post hCG trigger: a proof of concept study

Serum Progesterone Is Lower in Ovarian Stimulation With Highly Purified HMG Compared to Recombinant FSH Owing to a Different Regulation of Follicular Steroidogenesis: A Randomized Controlled Trial

Association between progesterone level on human chronic gonadotropin (hcg) trigger day and clincal outcomes of cleavage-stage embryos or blastocysts transfer in assisted reproduction technology (art) cycles.

Controlled ovarian hyperstimulation leads to high progesterone and estradiol levels during early pregnancy

Impact of blood levels of progesterone on the day of ovulation onset on clinical, laboratory and reproductive parameters of young patients undergoing assisted reproduction: a cross-sectional study

Effect of HCG-day serum progesterone and oestradiol concentrations on pregnancy outcomes in GnRH agonist cycles

High responders are not exempt from detrimental effects of prematurely rising progesterone levels in fresh embryo transfer cycles

Elevated serum progesterone levels on the day of human chorionic gonadotropin administration do not predict outcome in assisted reproduction cycles

[Dynamic Assay of Serum Inhibin B and Estradiol Concentrations Obtained after Gonadotrophin Therapy As Predictors of Ovarian Response in Vitro Fertilization Cycle].

Estradiol Decline Before hCG Administration in COH Has a Negative Effect on IVF Outcomes in Patients Without OC Pretreatment

Premature progesterone elevation does not alter oocyte quality in in vitro fertilization

Does high serum progesterone level on the day of human chorionic gonadotropin administration affect pregnancy rate after intracytoplasmic sperm injection and embryo transfer?